Long-term obeticholic acid treatment leads to reversal or stabilization of fibrosis/cirrhosis in patients with PBC European Association For The Study Of The Liver 13 April 2018, Paris, France: The first results from the POISE biopsy sub-study have today confirmed that long-term treatment with obeticholic acid (OCA) leads to the reversal or stabilization of fibrosis/cirrhosis in…
The post Long-term obeticholic acid treatment appeared first on Living With Liver Disease.
